Empresa Synta Pharmaceuticals Corp. Nasdaq
Acciones
US87162T2069
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
23/04 | MADRIGAL PHARMACEUTICALS, INC. : BofA Securities baja su recomendación a Vender | ZM |
23/04 | MADRIGAL PHARMACEUTICALS, INC. : Cambia de Compra a Venta por el BofA Securities | ZM |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Edward Chiang
FOU | Founder | - | 01/09/11 |
William Sibold
CEO | Chief Executive Officer | - | 08/09/23 |
Rebecca Taub
FOU | Founder | 71 | 01/07/16 |
Ronald Filippo
CTO | Chief Tech/Sci/R&D Officer | - | 21/11 |
Stephen Dodge
CTO | Chief Tech/Sci/R&D Officer | - | - |
Paul Friedman
BRD | Director/Board Member | 81 | 22/07/16 |
Tina Ventura
IRC | Investor Relations Contact | - | 29/01 |
Carole Huntsman
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 10/01/22 | |
Corporate Officer/Principal | 60 | 02/08/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 78 | 01/09/11 | |
Julian Baker
CHM | Chairman | 57 | 15/06/23 |
Ken Bate
BRD | Director/Board Member | 73 | 22/07/16 |
Paul Friedman
BRD | Director/Board Member | 81 | 22/07/16 |
Richard Levy
BRD | Director/Board Member | 66 | 11/08/16 |
Rebecca Taub
FOU | Founder | 71 | 01/07/16 |
William Sibold
CEO | Chief Executive Officer | - | 08/09/23 |
James Daly
BRD | Director/Board Member | 63 | 27/06/19 |
Raymond Cheong
BRD | Director/Board Member | 42 | 15/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 21 284 598 | 17 861 525 ( 83,92 %) | 0 | 83,92 % |
Información de la empresa
Madrigal Pharmaceuticals, Inc.
200 Barr Harbor Drive Suite 200
19428, West Conshohocken
+267 824 2827
http://www.madrigalpharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,96 % | 105 mil M | |
-1,43 % | 104 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+38,61 % | 12,63 mil M | |
+313,59 % | 8487,34 M |
- Bolsa de valores
- Acciones
- Acción MDGL
- Acción
- Empresa Synta Pharmaceuticals Corp.